Donald Malone, Jr., MD

Donald Malone, Jr., MD
  • Watch Video
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments

Donald Malone, Jr., MD

Department Psychiatry and Psychology
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No
Locations
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus

Appointment:
216.636.5860
Desk:
216.444.5817
Fax:
216.445.0127
Specialties & Treatments

Treatment & Services

  • 2nd Opinion Evaluations
  • Adult Psychoparmacology
  • Clinical Trials
  • Consultation/treatment Planning
  • Deep Brain Stimulation (DBS)
  • Electroconvulsive Therapy
  • Medication Management
  • Psychopharmacology
  • Sports Psychiatry
View all 9 Treatment & Services +

Specialty in Diseases & Conditions

  • Anxiety Disorder
  • Depression
  • Depressive Disorders
  • Major Depression
  • Mood Disorder
  • Obsessive-Compulsive Disorder (OCD)
  • Psychiatric Disorders
View all 7 Specialties +
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About Donald Malone, Jr., MD

Donald A. Malone, Jr., MD, is currently a Staff Psychiatrist at Cleveland Clinic. He also performs duties as Section Head of Adult Primary Psychiatric Services and Director of the Psychiatric Neuromodulation Center.
 
Dr. Malone graduated with his MD degree from Northeastern Ohio University?s College of Medicine in 1985. There he was a member of Alpha Omega Alpha. Following his medical school training, he did one year of internship in internal medicine followed by a psychiatric residency at Massachusetts General Hospital. He was Chief Resident of the acute psychiatry service at Massachusetts General during his final year. Since 1989, he has been at Cleveland Clinic. 

Dr. Malone has been very active in research, education and various local and national committees. He has held positions in the Ohio Psychiatric Association, American Psychiatric Association, the Association for Convulsive Therapy, and American College of Psychiatrists. He is Past-President and on the Board of Directors of the Association for Convulsive Therapy.
 
His research has been primarily in the areas of anxiety disorders, anabolic steroid use and abuse, ECT and, most recently, deep-brain stimulation. He has authored a number of publications in these areas and presented both nationally and internationally. His current research focuses primarily on the use of deep-brain stimulation in psychiatric disorders.

Education & Professional Highlights

Education & Professional Highlights

Appointed
1991

Education & Fellowships

Residency - Massachusetts General Hospital
Psychiatry
Boston, MA USA
1989

Internship - NEOUCOM/Western Reserve Care System
Internal Medicine
Youngstown, OH USA
1986

Medical School - Northeastern Ohio Universities College of Medicine
Rootstown, OH USA
1985

Additional Training

  • Graduate of Cleveland Clinic Executive Program in Practice Management, 1995

Professional Highlights

  • Board of Directors, Association for Convulsive Therapy
  • Board Examiner, American Board of Psychiatry and Neurology
  • Exemplary Psychiatrist Award, National Alliance for the Mentally Ill
  • Laughlin Fellow, American College of Psychiatrists
  • Fellow, American College of Psychiatrists

Certifications

  • Psychiatry

Specialty Interests

adult psychoparmacology, anxiety and mood disorders, anxiety disorders, depressive disorders, mood and anxiety disorders, mood disorders, OCD, Panic Disorder, Psychopharmacology, sports psychiatry, VNS and DBS

Awards & Honors

  • Phi Kappa Phi Honor Society, 1980 
  • Alpha Omega Alpha, 1985  
  • Laughlin Fellowship, American College of Psychiatrists, 1988  
  • Fellow, Academy of Psychosomatic Medicine, 1993  
  • President's Award, Ohio Psychiatric Association, 1994  
  • Member, American College of Psychiatrists, 1996  
  • President’s Award, Ohio Psychiatric Association, 1996  
  • Fellow, American Psychiatric Association, 1998  
  • “Top 3 Psychiatrists in Northeast Ohio,” <em>Northern Ohio Live m</em>agazine, 2001
  • Guide to Top Doctors, 2001-Present  
  • Exemplary Psychiatrist Award, National Alliance for the Mentally Ill, 2002  
  • Fellow, American College of Psychiatrists, 2002  
  • Distinguished Fellow, American Psychiatric Association, 2003  
  • &quot;Top Doc,&quot; <em>Cleveland </em>magazine, 2004-Present
  • Best Doctors in America, 2005-Present  
  • President, Association for Convulsive Therapy, 2006-2008

Innovations & Patents

  • Involved with pioneering developments in the use of deep-brain stimulation for highly refractory patients with obsessive-compulsive disorder and major depression

Memberships

  • Fellow, American College of Psychiatrists
  • Distinguished Fellow, American Psychiatric Association
  • Society for Neuroscience
  • Association for Convulsive Therapy
  • North American Neuromodulation Society
Research & Publications

Research & Publications

See publications for Donald Malone, Jr., MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 9/28/2016, Dr. Malone, Jr. has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Related Videos